• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Talaris Therapeutics, Inc. - Common Stock (NQ:TALS)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 19, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 2.700 (4)
Ask (Size) 2.750 (6)
Prev. Close 2.720
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 42,166,025
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
October 18, 2023
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court... 
Via Benzinga
Topics Bankruptcy
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 06, 2023
 
Via Benzinga

Performance

More News

Read More
News headline image
TALARIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Talaris Therapeutics, Inc. - TALS
September 28, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Talaris Therapeutics, Inc. (Nasdaq - TALS), Inpixon® (Nasdaq - INPX)
August 01, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
July 28, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
July 26, 2023
Via Benzinga
News headline image
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Talaris Therapeutics, Inc. (Nasdaq – TALS)
June 26, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
TALARIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Talaris Therapeutics, Inc. - TALS
June 24, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet ↗
June 22, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
June 22, 2023
Via Benzinga
News headline image
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
June 22, 2023
Via Benzinga
News headline image
Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher ↗
June 22, 2023
Via Benzinga
News headline image
Why Talaris Therapeutics Stock Is Shooting Higher Today ↗
June 22, 2023
Via Benzinga
News headline image
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
June 22, 2023
Via FinancialNewsMedia
News headline image
US Stocks Lower Following Initial Jobless Claims Report ↗
June 22, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
June 22, 2023
Via Benzinga
News headline image
TALS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Talaris Therapeutics, Inc. Is Fair to Shareholders
June 22, 2023
From Halper Sadeh LLC
Via Business Wire
News headline image
Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗
April 27, 2023
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗
April 17, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
February 16, 2023
Via Benzinga
News headline image
CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday ↗
October 24, 2022
Via Benzinga
News headline image
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
February 16, 2023
Via Benzinga
News headline image
US Stocks Turn Lower; Dow Tumbles Over 100 Points ↗
October 20, 2022
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
December 20, 2022
Via Benzinga
News headline image
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday ↗
October 21, 2022
Via Benzinga

Frequently Asked Questions

Is Talaris Therapeutics, Inc. - Common Stock publicly traded?
Yes, Talaris Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Talaris Therapeutics, Inc. - Common Stock trade on?
Talaris Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Talaris Therapeutics, Inc. - Common Stock?
The ticker symbol for Talaris Therapeutics, Inc. - Common Stock is TALS on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap